Associations between Sleep Quality and Serum Levels of Neurofilament Light in Individuals with Premanifest Huntington Disease

被引:0
|
作者
Turner, Mitchell [1 ,2 ]
Bartlett, Danielle [2 ]
Poudel, Govinda [3 ]
Zaenker, Pauline [1 ,2 ]
Laws, Simon [1 ,2 ]
Lo, Johnny [4 ]
Ziman, Mel [2 ]
Cruickshank, Travis [1 ,2 ,5 ]
机构
[1] Edith Cowan Univ, Ctr Precis Hlth, Perth, WA 6027, Australia
[2] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia
[3] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Melbourne, Vic, Australia
[4] Edith Cowan Univ, Sch Sci, Perth, WA, Australia
[5] Perron Inst Neurol & Translat Sci, Perth, WA, Australia
关键词
sleep quality; Huntington disease; neurofilament proteins;
D O I
10.1055/s-0043-1777783
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives To evaluate the associations between sleep quality and serum levels of neurofilament light (NfL) protein in individuals with premanifest Huntington disease (HD). Materials and Methods We recruited 28 individuals with premanifest HD from a pre-existing database (of the Huntington's Environmental Research Optimisation Scheme, HEROs). The participants filled out the Pittsburgh Sleep Quality Index (PSQI), a subjective measure of sleep quality, and blood was collected via routine venepuncture to measure peripheral NfL levels. Results The PSQI scores (median: 5.0; interquartile range: 4.0-7.5) indicated poor sleep quality. General linear modelling revealed no significant ( p = 0.242) association between PSQI scores and NfL levels. No significant differences were found between individuals with good and poor sleep quality for any demographic variable collected. Discussion Contrary to studies on other neurological conditions, there was no association between sleep quality and NfL levels in individuals with premanifest HD. This was unexpected, given the influence of environmental factors (such as social network size) on neurodegeneration in individuals with premanifest HD.
引用
收藏
页码:e199 / e202
页数:4
相关论文
共 50 条
  • [1] Associations of sleep disorders with serum neurofilament light chain levels in Parkinson's disease
    Qi, Wan-Yi
    Sun, Yan
    Guo, Yun
    Tan, Lan
    BMC NEUROLOGY, 2024, 24 (01)
  • [2] The relationship between lifestyle and serum neurofilament light protein in Huntington's disease
    Cruickshank, Travis
    Bartlett, Danielle
    Govus, Andrew
    Hannan, Anthony
    Teo, Wei-Peng
    Mason, Sarah
    Lo, Johnny
    Ziman, Mel
    BRAIN AND BEHAVIOR, 2020, 10 (05):
  • [3] Associations between prognostic index scores and plasma neurofilament light in Huntington's disease
    Parkin, Georgia M.
    Corey-Bloom, Jody
    Long, Jeffrey D.
    Snell, Chase
    Smith, Haileigh
    Thomas, Elizabeth A.
    PARKINSONISM & RELATED DISORDERS, 2022, 97 : 25 - 28
  • [4] Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease
    Li, Yangdanyu
    Li, Fujia
    Liu, Xu
    Zu, Jie
    Zhang, Wei
    Zhou, Su
    Zhu, Jienan
    Zhang, Tao
    Cui, Guiyun
    Xu, Chuanying
    NEUROSCIENCE LETTERS, 2023, 812
  • [5] Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease
    Heim, Beatrice
    Mandler, Elias
    Buchmann, Arabella
    Grossauer, Anna
    Peball, Marina
    Valent, Dora
    Carbone, Federico
    Schwarzova, Katarina
    Djamshidian, Atbin
    Mahlknecht, Philipp
    Khalil, Michael
    Krismer, Florian
    Seppi, Klaus
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (07): : 912 - 913
  • [6] THE EFFECT OF MULTIDISCIPLINARY THERAPY ON OBJECTIVE AND SUBJECTIVE SLEEP QUALITY IN PREMANIFEST HUNTINGTON'S DISEASE
    Bartlett, Danielle
    Cruickshank, Travis
    Lazar, Alpar
    Lampit, Amit
    Slater, James
    Rankin, Tim
    Hoult, Linda
    Pulverenti, Tim
    Govus, Andrew
    Power, Brian
    Reyes, Alvaro
    Newton, Rob
    Hannan, Anthony
    Eastwood, Peter
    Ziman, Mel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A107 - A108
  • [7] Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease
    Wesson, Melissa
    Boileau, Nicholas R.
    Perlmutter, Joel S.
    Paulsen, Jane S.
    Barton, Stacey K.
    McCormack, Michael K.
    Carlozzi, Noelle E.
    JOURNAL OF HUNTINGTONS DISEASE, 2018, 7 (03) : 239 - 249
  • [8] A 14-year longitudinal study of neurofilament light chain dynamics in premanifest and transitional Huntington's disease
    Voysey, Z. J.
    Owen, N. E.
    Holbrook, J. A.
    Malpetti, M.
    Le Draoulec, C.
    Spindler, L. R. B.
    Goodman, A. O. G.
    Lazar, A. S.
    Barker, R. A.
    JOURNAL OF NEUROLOGY, 2024, 271 (12) : 7572 - 7582
  • [9] Application Value of Serum Neurofilament Light Protein for Disease Staging in Huntington's Disease
    Li, Xiao-Yan
    Bao, Yu-Feng
    Xie, Juan-Juan
    Gao, Bin
    Qian, Shu-Xia
    Dong, Yi
    Wu, Zhi-Ying
    MOVEMENT DISORDERS, 2023, 38 (07) : 1307 - 1315
  • [10] Sleep Deficits But No Metabolic Deficits in Premanifest Huntington's Disease
    Lazar, Alpar S.
    Panin, Francesca
    Goodman, Anna O. G.
    Lazic, Stanley E.
    Lazar, Zsolt I.
    Mason, Sarah L.
    Rogers, Lorraine
    Murgatroyd, Peter R.
    Watson, Laura P. E.
    Singh, Priya
    Borowsky, Beth
    Shneerson, John M.
    Barker, Roger A.
    ANNALS OF NEUROLOGY, 2015, 78 (04) : 630 - 648